DALLAS, Oct. 24, 2005 (PRIMEZONE) -- John Pentony, Publisher of StockGuru.com, announced today that the web site has initiated Profile Coverage of Response Biomedical Corporation (TSX-V:RBM) (OTCBB:RPBIF). Response Biomedical is commercializing a new class of diagnostic with the world's only immunoassay platform that provides lab quality information in a matter of minutes, anywhere, every time. RAMP(r) tests are commercially available for three cardiac markers used in the early detection of heart attack, biodefense applications, and environmental detection of West Nile virus.
Response Biomedical Corporation has received regulatory clearance from Health Canada and the U.S. Food and Drug Administration to market its RAMP Cardiac Marker Tests for detecting myoglobin, troponin I and CK-MB to assist in the rapid diagnosis of heart attack or acute myocardial infarction. RAMP is also the only independently validated rapid on-site detection system that enables first responders to quickly and confidently dismiss a hoax or positively identify a potentially infectious biological agent.
Since there are no effective vaccines or treatments for the West Nile virus, there is an urgent public health need for the virus' rapid and reliable detection. According to recent evaluations performed by the U.S. Centers for Disease Control and Prevention, the RAMP West Nile Virus (WNV) Test is more than 100 times as sensitive as any other commercially available rapid environmental WNV test.
To view the StockGuru.com Profile for Response Biomedical Corporation, please visit: http://www.stockguru.com/profiles/rpbif/index.php
About StockGuru.com
StockGuru.com features daily alerts going out three times daily to members. To join our email alert list, please visit: http://www.stockguru.com/stocks.htm
To feature your publicly traded company in our alerts, or to discuss our complete services, please contact: John Pentony at (469) 252-3031 or email publisher@stockguru.com.
Statements contained in this news release relating to future results, events and expectations, including statements relating to the proposed financing, are forward-looking statements within the meaning of Section 21E of the United States Securities Exchange Act of 1934. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievement of the Company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such statements. Such factors include, among others, those described in the Company's annual report on Form 20-F.
Disclosure: Pentony Enterprises LLC was compensated up to $10,000 for profile coverage. Pentony Enterprises LLC is not a registered investment advisers or broker/dealers. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.